Skip to content

A multicenter, randomized, controlled trial for the Crossbow drug-acupuncture therapy of Miao Medicine in the treatment of knee osteoarthritis

A multicenter, randomized, controlled trial for the Crossbow drug-acupuncture therapy of Miao Medicine in the treatment of knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008032
Enrollment
Unknown
Registered
2016-03-12
Start date
2016-04-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

The treatment group:the Crossbow drug-acupuncture therapy of Miao Medicine

Sponsors

Guiyang college of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) conform to the appeals for knee osteoarthritis western medicine diagnostic criteria ((1) + (2) or (1) + (4) + (5) + (6), if the patient (1) + (2) diagnosis standard, only choose K - L class I, II and III) and miao medical certificate inter-cooled selection in the knee joint bone for it; (2) Aged 40 to 75 years, male and female; (3) if both sides are diagnosed with knee osteoarthritis, symptoms will be incorporated into the heavier side; (4) no history of knee osteoarthritis quantitative treatment in past one week; (5) have a correct understanding on the research significance, the observation and evaluation of researchers with good compliance; (6) have signed informed consent; Note: to conform to the above six patients at the same time, shall be included in the study.

Exclusion criteria

Exclusion criteria: (1) do not meet above diagnostic criteria and inclusion criteria, pregnant women or nursing mothers, easy allergic constitution; (2) the concurrent with other bone diseases such as knee joint tuberculosis, tumour, acute injury of meniscus injuries, ligament around, rheumatism and rheumatoid arthritis and so on do not belong to the patients with knee osteoarthritis; (3) of knee, ankle foot hurt or other outside of the injured; (4) the ankle foot deformity, pain and other lesions affecting the normal walking; (5) the operation of local skin infection or deep have swollen; (6) combined cardiovascular, cerebrovascular, liver and kidney, hematopoietic system, endocrine system and other serious complications or primary diseases and mental illness; Note: all patients comply with any of the above, which should be ruled out.

Design outcomes

Primary

MeasureTime frame
The knee joint WOMAC score;

Secondary

MeasureTime frame
Knee joint Lysholm score;JOA knee osteoarthritis treatment decision criteria;Visual simulation VAS score;Quality of Life;

Countries

China

Contacts

Public ContactCujin
516260179@qq.com+86 13985026278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026